<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mestriner AB</submitter><funding>Vericel Corporation</funding><pagination>1298S-1305S</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8808922</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1_suppl)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>To determine the relationship between cartilage lesion etiology and clinical outcomes after second-generation autologous chondrocyte implantation (ACI) in the patellofemoral joint (PFJ) with a minimum of 2 years' follow-up.&lt;h4>Methods&lt;/h4>A retrospective review of all patients that underwent ACI in the PFJ by a single surgeon was performed. Seventy-two patients with a mean follow-up of 4.2 ± 2.0 years were enrolled in this study and were stratified into 3 groups based on the etiology of PFJ cartilage lesions: patellar dislocation (group 1; &lt;i>n&lt;/i> = 23); nontraumatic lesions, including chondromalacia, osteochondritis dissecans, and degenerative defects (group 2; &lt;i>n&lt;/i> = 28); and other posttraumatic lesions besides patellar dislocations (group 3; &lt;i>n&lt;/i> = 21). Patien</pubmed_abstract><journal>Cartilage</journal><pubmed_title>Etiology of Cartilage Lesions Does Not Affect Clinical Outcomes of Patellofemoral Autologous Chondrocyte Implantation.</pubmed_title><pmcid>PMC8808922</pmcid><funding_grant_id>20180814</funding_grant_id><pubmed_authors>Mestriner AB</pubmed_authors><pubmed_authors>Merkely G</pubmed_authors><pubmed_authors>Ambra LFM</pubmed_authors><pubmed_authors>Gomoll AH</pubmed_authors><pubmed_authors>Ackermann J</pubmed_authors><pubmed_authors>Galvao PHSAF</pubmed_authors></additional><is_claimable>false</is_claimable><name>Etiology of Cartilage Lesions Does Not Affect Clinical Outcomes of Patellofemoral Autologous Chondrocyte Implantation.</name><description>&lt;h4>Objective&lt;/h4>To determine the relationship between cartilage lesion etiology and clinical outcomes after second-generation autologous chondrocyte implantation (ACI) in the patellofemoral joint (PFJ) with a minimum of 2 years' follow-up.&lt;h4>Methods&lt;/h4>A retrospective review of all patients that underwent ACI in the PFJ by a single surgeon was performed. Seventy-two patients with a mean follow-up of 4.2 ± 2.0 years were enrolled in this study and were stratified into 3 groups based on the etiology of PFJ cartilage lesions: patellar dislocation (group 1; &lt;i>n&lt;/i> = 23); nontraumatic lesions, including chondromalacia, osteochondritis dissecans, and degenerative defects (group 2; &lt;i>n&lt;/i> = 28); and other posttraumatic lesions besides patellar dislocations (group 3; &lt;i>n&lt;/i> = 21). Patien</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2025-04-04T07:47:55.721Z</modification><creation>2025-04-04T07:47:55.721Z</creation></dates><accession>S-EPMC8808922</accession><cross_references><pubmed>34286619</pubmed><doi>10.1177/19476035211030991</doi></cross_references></HashMap>